Cellular and molecular cross‐talk in atrial fibrillation: The role of non‐cardiomyocytes in creating an arrhythmogenic substrate
The Journal of Physiology · 2026
DOI: 10.1113/jp286978 ↗At a glance
Übersichtsarbeit in The Journal of Physiology, 2026. Written by Zhenyu Dong and 2 co-authors. Institution: Department of Clinical and Experimental Cardiology and Cardiothoracic Surgery, Heart Center, Amsterdam UMC, University of Amsterdam, Amsterdam, The N…. Major MEDLINE topics: Atrial Fibrillation, Myocytes, Cardiac. Cited 15 times so far (Crossref); 133 references. The full text is freely available (open access, CC BY 4.0). Funded by: The information technology for european advancement ITEA4 grant, The CVON/Dutch heart foundation grant, European Research Area for Health(ERA4Health) consortium grant.
Abstract (original language)
Atrial fibrillation (AF) is a complex arrhythmia. Various modulating factors influence its triggers and substrate. Fibroblasts, adipocytes, inflammatory cells and the coagulation system can disrupt cardiomyocyte function. Cardiomyocytes and fibroblasts release inflammatory cytokines that promote local and systemic inflammation, enhancing fibroblast activation and extracellular matrix deposition, leading to myocardial fibrosis. Fibrosis is essential for the induction of reentrant arrhythmias, including AF. Adipocytes contribute to arrhythmogenesis by secreting pro‐inflammatory and pro‐fibrotic factors, exacerbating inflammation and metabolic dysregulation. Inflammatory mediators activate the coagulation system, which augments this vicious cycle by producing factors promoting inflammation, fibrosis and arrhythmias at the same time as increasing the risk of thrombosis. Understanding these interconnected roles in the development and progress of the atrial arrhythmogenic substrate may point to potential novel therapeutic targets to stabilise or antagonise the atrial substrate and eventually prevent AF. This review examines the role of the interplay between cardiomyocytes, fibroblasts, adipocytes, inflammation and the coagulation system in contributing to the arrhythmogenic substrate for AF initiation and perpetuation. image
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Clinical and Experimental Cardiology and Cardiothoracic Surgery, Heart Center, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
- Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Amsterdam, The Netherlands.
ORCID profiles: Zhenyu Dong, Ruben Coronel
Funding
- The information technology for european advancement ITEA4 grant
- The CVON/Dutch heart foundation grant
- European Research Area for Health(ERA4Health) consortium grant
Cite
APA
Dong, Z., Coronel, R., & de Groot, J. R. (2026). Cellular and molecular cross‐talk in atrial fibrillation: The role of non‐cardiomyocytes in creating an arrhythmogenic substrate. The Journal of Physiology. https://doi.org/10.1113/jp286978
Vancouver
Dong Z, Coronel R, de Groot JR. Cellular and molecular cross‐talk in atrial fibrillation: The role of non‐cardiomyocytes in creating an arrhythmogenic substrate. The Journal of Physiology. 2026. doi:10.1113/jp286978
BibTeX
@article{Dong2026,
author = {Dong, Zhenyu and Coronel, Ruben and de Groot, Joris R},
title = {Cellular and molecular cross‐talk in atrial fibrillation: The role of non‐cardiomyocytes in creating an arrhythmogenic substrate},
journal = {The Journal of Physiology},
year = {2026},
doi = {10.1113/jp286978}
}
EUVIMED